Found 31 matching trials
MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH) PHASE3 This is an open-label, multi-center, randomized, phase III study. It is aim...
Show More Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Learn More & Join Trial
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma N/A Pediatric soft tissue sarcoma is made up of different subtypes, some of whi...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study) N/A Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses ...
Show More Location
Linkou Chang Gung Memorial Hospital
Learn More & Join Trial
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS N/A The second generation of high-throughput gene sequencing (NGS) is an import...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study NA For patients with stage III colon cancers, radical resection of primary tum...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy PHASE2 Befotertinib is a third-generation EGFR-TKI independently developed in Chin...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR N/A This was a prospective, single-center clinical study. The study was designe...
Show More Location
Chinese Academy of Medical Sciences
Learn More & Join Trial
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients N/A 1. To explore the predictive value of ctDNA in HER2 positive breast cancer ...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer PHASE2 This study will utilize ctDNA methylation detection to evaluate patients wi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC N/A The goal of this observational study is to explore whether ctDNA dynamic mo...
Show More Location
Department of Thoracic Surgery, Second Xiangya Hospital of Central South University, China
Learn More & Join Trial